Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.

Jacquemont L, Tilly G, Yap M, Doan-Ngoc TM, Danger R, Guérif P, Delbos F, Martinet B, Giral M, Foucher Y, Brouard S, Degauque N.

J Am Soc Nephrol. 2020 Mar 12. pii: ASN.2019080847. doi: 10.1681/ASN.2019080847. [Epub ahead of print]

PMID:
32165419
2.

External Validation of the DynPG for Kidney Transplant Recipients.

Lenain R, Dantan E, Giral M, Foucher Y, Asar Ö, Naesens M, Hazzan M, Fournier MC.

Transplantation. 2020 Feb 27. doi: 10.1097/TP.0000000000003209. [Epub ahead of print]

PMID:
32108750
3.

Predictive medicine in multiple sclerosis: A systematic review.

Havas J, Leray E, Rollot F, Casey R, Michel L, Lejeune F, Wiertlewski S, Laplaud D, Foucher Y.

Mult Scler Relat Disord. 2020 Jan 2;40:101928. doi: 10.1016/j.msard.2020.101928. [Epub ahead of print] Review.

PMID:
32004856
4.

The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research.

Lorent M, Foucher Y, Kerleau K, Brouard S, Baayen C, Lebouter S, Naesens M, Bestard Matamoros O, Åsberg A, Giral M; EKiTE consortium.

BMC Nephrol. 2019 Oct 11;20(1):365. doi: 10.1186/s12882-019-1522-8.

5.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

6.

Induction Therapy in Elderly Kidney Transplant Recipients With Low Immunological Risk.

Masset C, Boucquemont J, Garandeau C, Buron F, Morelon E, Girerd S, Ladrière M, Mourad G, Garrigue V, Cassuto E, Albano L, Foucher Y, Dantal J, Badet L, Brunet M, Buron F, Cahen R, Daoud S, Fournie C, Grégoire A, Koenig A, Lévi C, Morelon E, Pouteil-Noble C, Rimmelé T, Thaunat O, Delmas S, Garrigue V, Le Quintrec M, Pernin V, Serre JE, Eschwege P, Frimat L, Girerd S, Hubert J, Ladriere M, Laurain E, Leblanc L, Lecoanet P, Lemelle JL, Blancho G, Branchereau J, Cantarovich D, Chapelet A, Dantal J, Deltombe C, Figueres L, Garandeau C, Giral M, Gourraud-Vercel C, Hourmant M, Karam G, Kerleau C, Meurette A, Ville S, Kandell C, Moreau A, Renaudin K, Cesbron A, Delbos F, Walencik A, Devis A, Albano L, Cassuto E; DIVAT Consortium; Lyon E. Hériot:; Montpellier:; Nancy:; Nantes:; Nice:.

Transplantation. 2020 Mar;104(3):613-622. doi: 10.1097/TP.0000000000002804.

PMID:
31283665
7.

Dynamic predictions of long-term kidney graft failure: an information tool promoting patient-centred care.

Fournier MC, Foucher Y, Blanche P, Legendre C, Girerd S, Ladrière M, Morelon E, Buron F, Rostaing L, Kamar N, Mourad G, Garrigue V, Couvrat-Desvergnes G, Giral M, Dantan E; DIVAT Consortium.

Nephrol Dial Transplant. 2019 Nov 1;34(11):1961-1969. doi: 10.1093/ndt/gfz027.

PMID:
30859193
8.

Meta-analysis of predictive models to assess the clinical validity and utility for patient-centered medical decision making: application to the CAncer of the Prostate Risk Assessment (CAPRA).

Lorent M, Maalmi H, Tessier P, Supiot S, Dantan E, Foucher Y.

BMC Med Inform Decis Mak. 2019 Jan 7;19(1):2. doi: 10.1186/s12911-018-0727-2.

9.

Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer.

Caruana E, Foucher Y, Tessier P, Frenel JS, Classe JM, Dantan E.

Breast Cancer Res Treat. 2019 Apr;174(2):537-542. doi: 10.1007/s10549-018-05107-6. Epub 2019 Jan 2.

PMID:
30603997
10.

Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication.

Sénage T, Gillaizeau F, Le Tourneau T, Marie B, Roussel JC, Foucher Y.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1383-1390.e5. doi: 10.1016/j.jtcvs.2018.08.086. Epub 2018 Sep 26.

PMID:
30415900
11.

Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study.

Foucher Y, Le Borgne F, Legendre C, Morelon E, Buron F, Girerd S, Ladrière M, Mourad G, Garrigue V, Glotz D, Lefaucheur C, Cassuto E, Albano L, Giral M.

Nephrol Dial Transplant. 2019 May 1;34(5):886-891. doi: 10.1093/ndt/gfy317.

PMID:
30325453
12.

An early increase in endothelial protein C receptor is associated with excess mortality in pneumococcal pneumonia with septic shock in the ICU.

Chapelet A, Foucher Y, Gérard N, Rousseau C, Zambon O, Bretonnière C, Mira JP, Charreau B, Guitton C.

Crit Care. 2018 Oct 5;22(1):251. doi: 10.1186/s13054-018-2179-6.

13.

Comparison of graft and patient survival according to the transplantation centre policy for 1-year screening biopsy among stable kidney recipients: a propensity score-based study.

Couvrat-Desvergnes G, Foucher Y, Le Borgne F, Dion A, Mourad G, Garrigue V, Legendre C, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Giral M, Dantan E.

Nephrol Dial Transplant. 2019 Apr 1;34(4):703-711. doi: 10.1093/ndt/gfy221.

PMID:
30060106
14.

The 1-year Renal Biopsy Index: a scoring system to drive biopsy indication at 1-year post-kidney transplantation.

Giral M, Renaudin K, Naesens M, Luning R, Anglicheau D, Morelon E, Huneau A, Paul C, Brouard S, Couvrat-Desvergnes G, Foucher Y, Dantan E.

Transpl Int. 2018 Jun 12. doi: 10.1111/tri.13290. [Epub ahead of print] Review.

15.

A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.

Foucher Y, Lorent M, Tessier P, Supiot S, Sébille V, Dantan E.

Health Qual Life Outcomes. 2018 Mar 5;16(1):40. doi: 10.1186/s12955-018-0870-6. Review.

16.

Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donors.

Querard AH, Le Borgne F, Dion A, Giral M, Mourad G, Garrigue V, Rostaing L, Kamar N, Loupy A, Legendre C, Morelon E, Buron F, Foucher Y, Dantan E.

Am J Transplant. 2018 May;18(5):1151-1157. doi: 10.1111/ajt.14651. Epub 2018 Feb 8.

17.

Ventilator-Free Day Outcomes Can Be Misleading.

Bodet-Contentin L, Frasca D, Tavernier E, Feuillet F, Foucher Y, Giraudeau B.

Crit Care Med. 2018 Mar;46(3):425-429. doi: 10.1097/CCM.0000000000002890.

PMID:
29227369
18.

Inverse probability weighting to control confounding in an illness-death model for interval-censored data.

Gillaizeau F, Sénage T, Le Borgne F, Le Tourneau T, Roussel JC, Leffondrè K, Porcher R, Giraudeau B, Dantan E, Foucher Y.

Stat Med. 2018 Apr 15;37(8):1245-1258. doi: 10.1002/sim.7550. Epub 2017 Dec 4.

PMID:
29205409
19.

Horizontal mixture model for competing risks: a method used in waitlisted renal transplant candidates.

Trébern-Launay K, Kessler M, Bayat-Makoei S, Quérard AH, Briançon S, Giral M, Foucher Y.

Eur J Epidemiol. 2018 Mar;33(3):275-286. doi: 10.1007/s10654-017-0322-3. Epub 2017 Oct 30.

PMID:
29086099
20.

Optimal threshold estimator of a prognostic marker by maximizing a time-dependent expected utility function for a patient-centered stratified medicine.

Dantan E, Foucher Y, Lorent M, Giral M, Tessier P.

Stat Methods Med Res. 2018 Jun;27(6):1847-1859. doi: 10.1177/0962280216671161. Epub 2016 Oct 20.

PMID:
28937334
21.

Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.

Deltombe C, Gillaizeau F, Anglicheau D, Morelon E, Trébern-Launay K, Le Borgne F, Rimbert M, Guérif P, Malard-Castagnet S, Foucher Y, Giral M.

Transpl Int. 2017 Nov;30(11):1150-1160. doi: 10.1111/tri.13009. Epub 2017 Oct 5.

22.

Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors.

Le Borgne F, Combescure C, Gillaizeau F, Giral M, Chapal M, Giraudeau B, Foucher Y.

Stat Methods Med Res. 2018 Nov;27(11):3397-3410. doi: 10.1177/0962280217702416. Epub 2017 Jun 20.

PMID:
28633603
23.

Tropism and virulence of Cutibacterium (formerly Propionibacterium) acnes involved in implant-associated infection.

Aubin GG, Lavigne JP, Foucher Y, Dellière S, Lepelletier D, Gouin F, Corvec S.

Anaerobe. 2017 Oct;47:73-78. doi: 10.1016/j.anaerobe.2017.04.009. Epub 2017 Apr 25.

PMID:
28454760
24.

Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients.

Dugast E, Soulillou JP, Foucher Y, Papuchon E, Guerif P, Paul C, Riochet D, Chesneau M, Cesbron A, Renaudin K, Dantal J, Giral M, Brouard S.

Am J Transplant. 2016 Nov;16(11):3255-3261. doi: 10.1111/ajt.13946. Epub 2016 Jul 29.

25.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Lanzillo R, Moccia M, Laplaud DA, Foucher Y.

Neurology. 2016 Sep 6;87(10):1066. doi: 10.1212/01.wnl.0000497026.62085.8d. No abstract available.

PMID:
27597557
26.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Bhatia R, Laplaud DA, Foucher Y.

Neurology. 2016 Sep 6;87(10):1065-6. doi: 10.1212/WNL.0000000000003112. No abstract available. Erratum in: Neurology. 2016 Nov 1;87(18):1961.

PMID:
27597556
27.

Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts.

Lorent M, Giral M, Pascual M, Koller MT, Steiger J, Trébern-Launay K, Legendre C, Kreis H, Mourad G, Garrigue V, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Golshayan D, Foucher Y.

PLoS One. 2016 May 6;11(5):e0155278. doi: 10.1371/journal.pone.0155278. eCollection 2016.

28.

A joint model for longitudinal and time-to-event data to better assess the specific role of donor and recipient factors on long-term kidney transplantation outcomes.

Fournier MC, Foucher Y, Blanche P, Buron F, Giral M, Dantan E.

Eur J Epidemiol. 2016 May;31(5):469-79. doi: 10.1007/s10654-016-0121-2. Epub 2016 Feb 1.

PMID:
26832337
29.

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

Barbin L, Rousseau C, Jousset N, Casey R, Debouverie M, Vukusic S, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Créange A, Labauge P, Magy L, Defer G, Foucher Y, Laplaud DA; CFSEP and OFSEP groups.

Neurology. 2016 Feb 23;86(8):771-8. doi: 10.1212/WNL.0000000000002395. Epub 2016 Jan 29.

30.

Propensity score to detect baseline imbalance in cluster randomized trials: the role of the c-statistic.

Leyrat C, Caille A, Foucher Y, Giraudeau B.

BMC Med Res Methodol. 2016 Jan 22;16:9. doi: 10.1186/s12874-015-0100-4.

31.

Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after a dialysis period of less than three years--The PreKit-QoL study protocol.

Sébille V, Hardouin JB, Giral M, Bonnaud-Antignac A, Tessier P, Papuchon E, Jobert A, Faurel-Paul E, Gentile S, Cassuto E, Morélon E, Rostaing L, Glotz D, Sberro-Soussan R, Foucher Y, Meurette A.

BMC Nephrol. 2016 Jan 19;17:11. doi: 10.1186/s12882-016-0225-7.

32.

Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta-analysis.

Querard AH, Foucher Y, Combescure C, Dantan E, Larmet D, Lorent M, Pouteau LM, Giral M, Gillaizeau F.

Transpl Int. 2016 Apr;29(4):403-15. doi: 10.1111/tri.12736. Epub 2016 Feb 12. Review.

33.

Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival.

Couvrat-Desvergnes G, Salama A, Le Berre L, Evanno G, Viklicky O, Hruba P, Vesely P, Guerif P, Dejoie T, Rousse J, Nicot A, Bach JM, Ang E, Foucher Y, Brouard S, Castagnet S, Giral M, Harb J, Perreault H, Charreau B, Lorent M, Soulillou JP.

J Clin Invest. 2015 Dec;125(12):4655-65. doi: 10.1172/JCI82267. Epub 2015 Nov 9.

34.

Comparisons of the performance of different statistical tests for time-to-event analysis with confounding factors: practical illustrations in kidney transplantation.

Le Borgne F, Giraudeau B, Querard AH, Giral M, Foucher Y.

Stat Med. 2016 Mar 30;35(7):1103-16. doi: 10.1002/sim.6777. Epub 2015 Oct 29.

PMID:
26514380
35.

PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial.

Chapal M, Foucher Y, Marguerite M, Neau K, Papuchon E, Daguin P, Morélon E, Mourad G, Cassuto E, Ladrière M, Legendre C, Giral M.

Trials. 2015 Jun 23;16:282. doi: 10.1186/s13063-015-0807-x.

36.

A multistate additive relative survival semi-Markov model.

Gillaizeau F, Dantan E, Giral M, Foucher Y.

Stat Methods Med Res. 2017 Aug;26(4):1700-1711. doi: 10.1177/0962280215586456. Epub 2015 Jun 7.

PMID:
26056059
37.

A personalized follow-up of kidney transplant recipients using video conferencing based on a 1-year scoring system predictive of long term graft failure (TELEGRAFT study): protocol for a randomized controlled trial.

Foucher Y, Meurette A, Daguin P, Bonnaud-Antignac A, Hardouin JB, Chailan S, Neau K, Papuchon E, Gaboriau S, Legendre C, Morélon E, Tessier P, Giral M.

BMC Nephrol. 2015 Jan 28;16:6. doi: 10.1186/1471-2369-16-6.

38.

Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients.

Sénage T, Le Tourneau T, Foucher Y, Pattier S, Cueff C, Michel M, Serfaty JM, Mugniot A, Périgaud C, Carton HF, Al Habash O, Baron O, Roussel JC.

Circulation. 2014 Dec 2;130(23):2012-20. doi: 10.1161/CIRCULATIONAHA.114.010400. Epub 2014 Oct 29.

PMID:
25355912
39.

Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation.

Debout A, Foucher Y, Trébern-Launay K, Legendre C, Kreis H, Mourad G, Garrigue V, Morelon E, Buron F, Rostaing L, Kamar N, Kessler M, Ladrière M, Poignas A, Blidi A, Soulillou JP, Giral M, Dantan E.

Kidney Int. 2015 Feb;87(2):343-9. doi: 10.1038/ki.2014.304. Epub 2014 Sep 17.

40.

Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.

Le Bourgeois A, Labopin M, Guillaume T, Delaunay J, Foucher Y, Tessoulin B, Malard F, Ayari S, Peterlin P, Derenne S, Herry P, Cesbron A, Gagne K, Lodé L, Illiaquer M, Imbert-Marcille BM, Le Gouill S, Moreau P, Mohty M, Chevallier P.

Exp Hematol. 2014 Nov;42(11):945-54. doi: 10.1016/j.exphem.2014.07.264. Epub 2014 Jul 26.

PMID:
25072620
41.

Buprenorphine prescription compliance: an original observational and longitudinal study.

Guillou Landreat M, Sebille-Rivain V, Victorri Vigneau C, Foucher Y, Venisse JL, Jolliet P.

J Psychoactive Drugs. 2014 Apr-Jun;46(2):162-7. doi: 10.1080/02791072.2014.904061.

PMID:
25052793
42.

CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.

Rabot N, Büchler M, Foucher Y, Moreau A, Debiais C, Machet MC, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J.

Transpl Int. 2014 Sep;27(9):956-65. doi: 10.1111/tri.12375. Epub 2014 Aug 20.

43.

A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors.

Chapal M, Le Borgne F, Legendre C, Kreis H, Mourad G, Garrigue V, Morelon E, Buron F, Rostaing L, Kamar N, Kessler M, Ladrière M, Soulillou JP, Launay K, Daguin P, Offredo L, Giral M, Foucher Y.

Kidney Int. 2014 Dec;86(6):1130-9. doi: 10.1038/ki.2014.188. Epub 2014 Jun 4.

44.

Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.

Yap M, Boeffard F, Clave E, Pallier A, Danger R, Giral M, Dantal J, Foucher Y, Guillot-Gueguen C, Toubert A, Soulillou JP, Brouard S, Degauque N.

J Am Soc Nephrol. 2014 Aug;25(8):1856-68. doi: 10.1681/ASN.2013080848. Epub 2014 Mar 20.

45.

An original approach was used to better evaluate the capacity of a prognostic marker using published survival curves.

Dantan E, Combescure C, Lorent M, Ashton-Chess J, Daguin P, Classe JM, Giral M, Foucher Y.

J Clin Epidemiol. 2014 Apr;67(4):441-8. doi: 10.1016/j.jclinepi.2013.10.022.

PMID:
24581297
46.

Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects.

Combescure C, Foucher Y, Jackson D.

Stat Med. 2014 Jul 10;33(15):2521-37. doi: 10.1002/sim.6111. Epub 2014 Feb 13.

PMID:
24532219
47.

Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality.

Lorent M, Giral M, Foucher Y.

Stat Med. 2014 Jun 30;33(14):2379-89. doi: 10.1002/sim.6079. Epub 2014 Jan 8.

PMID:
24399671
48.

Prognostic ROC curves: a method for representing the overall discriminative capacity of binary markers with right-censored time-to-event endpoints.

Combescure C, Perneger TV, Weber DC, Daurès JP, Foucher Y.

Epidemiology. 2014 Jan;25(1):103-9. doi: 10.1097/EDE.0000000000000004.

PMID:
24240658
49.

An alternative approach to estimate age-related mortality of kidney transplant recipients compared to the general population: results in favor of old-to-old transplantations.

Foucher Y, Akl A, Rousseau V, Trébern-Launay K, Lorent M, Kessler M, Ladrière M, Legendre C, Kreis H, Rostaing L, Kamar N, Mourad G, Garrigue V, Morelon E, Buron F, Daurès JP, Soulillou JP, Giral M.

Transpl Int. 2014 Feb;27(2):219-25. doi: 10.1111/tri.12241. Epub 2013 Dec 20.

50.

Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.

Giral M, Foucher Y, Dufay A, Van Huyen JP, Renaudin K, Moreau A, Philippe A, Hegner B, Dechend R, Heidecke H, Brouard S, Cesbron A, Castagnet S, Devys A, Soulillou JP, Dragun D.

Am J Transplant. 2013 Oct;13(10):2567-76. doi: 10.1111/ajt.12397. Epub 2013 Aug 6.

Supplemental Content

Loading ...
Support Center